Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs
Source: https://unsplash.com/photos/ZHys6xN7sUE

Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs

  Many patients with ankylosing spondylitis (AS) could be treated with biologics – in particular, biologic disease-modifying antirheumatic drugs (DMARDs). However, this line of treatment is not efficacious nor well-tolerated…

Continue Reading Upadacitinib Shows Efficacy in Treating Ankylosing Spondylitis Refractory to Biologic DMARDs
First Participant Dosed in IMG-004 Trial for Immunological Diseases
source: pixabay.com

First Participant Dosed in IMG-004 Trial for Immunological Diseases

  Near the start of August 2022, biotechnology company Inmagene Biopharmaceuticals ("Inmagene") and biopharmaceutical company HUTCHMED shared via news release that the first participant had been dosed in a Phase…

Continue Reading First Participant Dosed in IMG-004 Trial for Immunological Diseases
Health Canada Approves Hyrimoz for Ankylosing Spondylitis
stevepb / Pixabay

Health Canada Approves Hyrimoz for Ankylosing Spondylitis

According to GlobeNewswire, Health Canada has approved of a biosimilar, Hyrimoz, to treat ankylosing spondylitis and eight other rare conditions. Sandoz Canada is excited about this approval, as it expands…

Continue Reading Health Canada Approves Hyrimoz for Ankylosing Spondylitis
Promising New Treatments Beyond the Standards for Spondyloarthropathies
source: pixabay.com

Promising New Treatments Beyond the Standards for Spondyloarthropathies

by Lauren Taylor from In The Cloud Copy Spondyloarthropathies is an umbrella term for a group of chronic diseases that affect the joints. These can affect children and adults and…

Continue Reading Promising New Treatments Beyond the Standards for Spondyloarthropathies
Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19
source: pixabay.com

Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19

Michael George and his team from the University of Pennsylvania have recently uncovered new insights regarding autoimmune patient’s comfortability with care during COVID-19. They've been working since the pandemic began…

Continue Reading Study Examines Telehealth Visits for Patients with Autoimmune Conditions During COVID-19

Arthritis Treatment Shows Off-Target Benefits for Those Also Living with Diabetes

A recent study published in BMC Rheumatology has found that a combination therapy could have a benefit for individuals diagnosed with diabetes and ankylosing spondylitis (AS), psoriatic arthritis (PsA), or rheumatoid arthritis…

Continue Reading Arthritis Treatment Shows Off-Target Benefits for Those Also Living with Diabetes

Tennis Pro Caroline Wozniacki’s Advantage Hers Campaign Supports Women with Inflammatory Conditions

Caroline Wozniacki has led an interesting life. Born in Denmark, she was immediately thrust into athleticism. Her father was a former football player (that's soccer for you Americans) and her…

Continue Reading Tennis Pro Caroline Wozniacki’s Advantage Hers Campaign Supports Women with Inflammatory Conditions
Ankylosing Spondylitis Treatment Approved but Not Yet Available
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

Ankylosing Spondylitis Treatment Approved but Not Yet Available

According to Ankylosing Spondylitis News, a new treatment, Hulio, has been approved by the FDA. It is a treatment for ankylosing spondylitis and other inflammatory disorders. Although it has been…

Continue Reading Ankylosing Spondylitis Treatment Approved but Not Yet Available
Simponi Works for Patients with AS, RA, and PsA – Even with Prior TNF Inhibitor Treatment
mohamed_hassan / Pixabay

Simponi Works for Patients with AS, RA, and PsA – Even with Prior TNF Inhibitor Treatment

  In some cases, people have a medical condition that doesn't respond well to treatments. The journey to finding an effective treatment can be long and difficult. But for patients…

Continue Reading Simponi Works for Patients with AS, RA, and PsA – Even with Prior TNF Inhibitor Treatment

A Subcutaneous Form of Remsima May be Available Soon in the EU

Celltrion Healthcare has just announced positive progress for extending the authorization for the subcutaneous (SC) form of Remsima to five more autoimmune conditions. These are- Psoriatic arthritis Ankylosing spondylitis (AS)…

Continue Reading A Subcutaneous Form of Remsima May be Available Soon in the EU

New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)

At this year's EULAR 2020 E-Congress, Dr. Suzanne Verstappen, MD, presented on how lifestyle changes could benefit patients with rheumatic and musculoskeletal diseases (RMDs). Her interest in the impact of…

Continue Reading New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)
FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
source: pixabay.com

FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis

In a press release from Eli Lilly and Company, the company has announced recently that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (BLA)…

Continue Reading FDA Approves a New Treatment for Non-Radiographic Axial Spondyloarthritis
Ankylosing Spondylitis has Taken Her Mobility, and She Fears Her Daughter is Next
source: pixabay.com

Ankylosing Spondylitis has Taken Her Mobility, and She Fears Her Daughter is Next

For Emma, the worst part of receiving her diagnosis with ankylosing spondylitis wasn't adapting to the constant pain, losing her breath over five minutes of standing, being too exhausted to…

Continue Reading Ankylosing Spondylitis has Taken Her Mobility, and She Fears Her Daughter is Next